Latest Insider Transactions at Axogen, Inc. (AXGN)
This section provides a real-time view of insider transactions for Axogen, Inc. (AXGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Axogen, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Axogen, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 16
2024
|
Paul Thomas Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,875
+7.61%
|
-
|
Sep 13
2024
|
Erick Wayne De Vinney Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.37%
|
-
|
Sep 01
2024
|
Guido J Neels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,904
+11.59%
|
-
|
Sep 01
2024
|
John Johnson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,904
+29.09%
|
-
|
Sep 01
2024
|
Alan M Levine Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,904
+22.58%
|
-
|
Sep 01
2024
|
William P. Burke Mr. Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,904
+29.42%
|
-
|
Sep 01
2024
|
Paul Thomas Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,904
+27.08%
|
-
|
Sep 01
2024
|
Joseph A. Tyndall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,904
+34.54%
|
-
|
Sep 01
2024
|
Amy Mc Bride Wendell Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,904
+10.37%
|
-
|
Jun 06
2024
|
John Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,653
+38.37%
|
-
|
Jun 06
2024
|
William P. Burke Mr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,653
+39.01%
|
-
|
Jun 06
2024
|
Amy Mc Bride Wendell Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,653
+10.48%
|
-
|
Jun 06
2024
|
Alan M Levine Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,653
+26.93%
|
-
|
Jun 06
2024
|
Paul Thomas Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,653
+34.59%
|
-
|
Jun 06
2024
|
Kathy Johnson Weiler Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,653
+50.0%
|
-
|
Jun 06
2024
|
Joseph A. Tyndall Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,653
+50.0%
|
-
|
Jun 06
2024
|
Guido J Neels Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,653
+11.89%
|
-
|
Jun 04
2024
|
Gregory Gene Freitag Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,904
+4.03%
|
-
|
Mar 21
2024
|
Erick Wayne De Vinney Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
4,578
-0.87%
|
$32,046
$7.68 P/Share
|
Mar 21
2024
|
Karen L. Zaderej CEO |
SELL
Open market or private sale
|
Direct |
39,280
-1.13%
|
$274,960
$7.68 P/Share
|
Mar 21
2024
|
Angelo Scopelianos Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
6,881
-3.95%
|
$48,167
$7.68 P/Share
|
Mar 21
2024
|
Angelo Scopelianos Chief R&D Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+4.09%
|
-
|
Mar 21
2024
|
Michael Patrick Donovan VP Operations |
SELL
Open market or private sale
|
Direct |
6,033
-3.81%
|
$42,231
$7.68 P/Share
|
Mar 16
2024
|
Erick Wayne De Vinney Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,675
+3.36%
|
-
|
Mar 16
2024
|
Karen L. Zaderej CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
110,322
+3.01%
|
-
|
Mar 16
2024
|
Angelo Scopelianos Chief R&D Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,406
+16.75%
|
-
|
Mar 16
2024
|
Michael Patrick Donovan VP Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
24,575
+12.65%
|
-
|
Mar 07
2024
|
Gregory Gene Freitag Director |
SELL
Open market or private sale
|
Direct |
25,000
-8.43%
|
$225,000
$9.0 P/Share
|
Mar 07
2024
|
Michael Patrick Donovan VP Operations |
SELL
Open market or private sale
|
Direct |
36,310
-50.42%
|
$290,480
$8.81 P/Share
|
Mar 01
2024
|
Erick Wayne De Vinney Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+23.43%
|
-
|
Jan 01
2024
|
Nir Naor CFO |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+50.0%
|
-
|
Dec 11
2023
|
Peter J Mariani EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,500
-5.72%
|
$87,500
$7.51 P/Share
|
Oct 13
2023
|
Erick Wayne De Vinney Chief Innovation Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
864
-0.76%
|
$3,456
$4.04 P/Share
|
Oct 13
2023
|
Peter J Mariani EVP & Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,263
-4.11%
|
$13,052
$4.04 P/Share
|
Oct 13
2023
|
Maria D. Martinez Chief Human Resources Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,403
-4.4%
|
$5,612
$4.04 P/Share
|
Oct 13
2023
|
Angelo Scopelianos Chief R&D Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,403
-3.66%
|
$5,612
$4.04 P/Share
|
Oct 13
2023
|
Michael Patrick Donovan VP Operations |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,403
-1.91%
|
$5,612
$4.04 P/Share
|
Sep 06
2023
|
Amy Mc Bride Wendell Director |
BUY
Open market or private purchase
|
Direct |
10,000
+11.07%
|
$60,000
$6.22 P/Share
|
Aug 24
2023
|
William P. Burke Mr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+50.0%
|
$36,000
$6.31 P/Share
|
Aug 23
2023
|
William P. Burke Mr. Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+50.0%
|
$60,000
$6.56 P/Share
|
Aug 16
2023
|
Guido J Neels Director |
BUY
Open market or private purchase
|
Direct |
10,000
+12.78%
|
$60,000
$6.11 P/Share
|
Jul 18
2023
|
Erick Wayne De Vinney Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,579
+1.36%
|
-
|
Jul 18
2023
|
Peter J Mariani EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,709
+4.46%
|
-
|
Jul 18
2023
|
Karen L. Zaderej CEO |
BUY
Grant, award, or other acquisition
|
Direct |
22,076
+2.02%
|
-
|
Jul 18
2023
|
Maria D. Martinez Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,571
+7.46%
|
-
|
Jul 18
2023
|
Angelo Scopelianos Chief R&D Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,571
+6.28%
|
-
|
Jul 18
2023
|
Michael Patrick Donovan VP Operations |
BUY
Grant, award, or other acquisition
|
Direct |
2,571
+3.38%
|
-
|
Jun 01
2023
|
Alan M Levine Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,459
+26.13%
|
-
|
Jun 01
2023
|
Guido J Neels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,459
+9.98%
|
-
|
Jun 01
2023
|
John Johnson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,459
+50.0%
|
-
|